Results 121 to 130 of about 20,576 (195)

Efficacy of Aflibercept (8 mg) for Diabetic Macular Edema in Vitrectomized Eyes Refractory to the Other Anti-VEGF Drug Therapies: A Report of Three Cases

International Medical Case Reports Journal
Ikumi Kashiwagi, Ryota Nonaka, Shotaro Sasaki, Takuto Yamamoto, Kanako Yasuda, Masahiko Shimura Department of Ophthalmology, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, JapanCorrespondence: Masahiko Shimura, Department of ...
Kashiwagi I, Nonaka R, Sasaki S, Yamamoto T, Yasuda K, Shimura M   +5 more
doaj  

Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus Vial. [PDF]

Ophthalmol Ther
Hoffmann L, Hatz K.
europepmc   +1 more source

RE: Regorafenib Also Can Cause Osteonecrosis of the Jaw [PDF]

, 2016
Bedogni, A., Campisi, G., Fusco, V., Migliorati, C., Numico, G., Santini, D.   +5 more
core   +1 more source

Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]

J Ophthalmol
Veritti D, Misciagna M, Teatino C, Pontoni C, Blasutig M, Kuftic M, Pece S, Morsanutto A, Pece A, Lanzetta P.   +9 more
europepmc   +1 more source

Morphologic Changes of Macular Choroidal Neovascularization on OCT Angiography Following Faricimab Therapy in Patients With AMD. [PDF]

J Vitreoretin Dis
Loya A, Chen V, Siddiqui T, Rao P, Chang EY.   +4 more
europepmc   +1 more source

Aflibercept and Brolucizumab in Diabetic Macular Edema: A Focused Review of Efficacy, Safety, and Clinical Considerations. [PDF]

Biomedicines
Dascalu AM, Grigorescu CC, Ergin E, Alexandrescu C, Dumitrescu D, Nedea MI, Cristea BM, Serban D, Tribus LC, Badescu TM.   +9 more
europepmc   +1 more source

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]

J Comp Eff Res
Shi F, Tan S, Shu Y, Liu T, Xia Y, Buehrer C, Han S.   +6 more
europepmc   +1 more source

Evolution of Anti-Vascular Endothelial Growth Factor Clinical Trial Design for Treating Neovascular Age-Related Macular Degeneration. [PDF]

J Vitreoretin Dis
Klufas MA, Regillo CD, Mandava NK, Miller EG.   +3 more
europepmc   +1 more source

Efficacy of a single dose switch from aflibercept to ranibizumab in the treatment of neovascular age-related macular degeneration. [PDF]

PLoS One
Iby J, Coulibaly L, Hollaus M, Yeghiazaryan L, Schmidt-Erfurth U, Bühl W, Sacu S.   +6 more
europepmc   +1 more source